questionsmedicales.fr
Composés hétérocycliques
Composés hétérocycliques à cycles fusionnés
Composés hétérobicycliques
Benzofuranes
Benzofuranes : Questions médicales fréquentes
Termes MeSH sélectionnés :
Neoplasm Recurrence, Local
Diagnostic
5
Intoxication
Tests toxicologiques
Analyse de sang
Analyse d'urine
Symptômes
Troubles neurologiques
Tests de dépistage
Benzofuranes
Historique médical
Exposition
Symptômes
5
Effets psychologiques
Anxiété
Éruptions cutanées
Démangeaisons
Système respiratoire
Irritation
Prévention
5
Prévention
Équipements de protection
Mesures de sécurité
Laboratoire
Gestion des déchets
Déchets dangereux
Traitements
5
Intoxication
Soins symptomatiques
Symptômes neurologiques
Médicaments
Soins d'urgence
Exposition
Décontamination
Absorption
Complications
5
Complications
Neurologiques
Maladies chroniques
Exposition prolongée
Effets à long terme
Troubles cognitifs
Reproduction
Effets néfastes
Suivi médical
Complications
Facteurs de risque
5
Travailleurs
Produits chimiques
Produits chimiques
Médicaments
Antécédents médicaux
Maladies respiratoires
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Benzofuranes : Questions médicales les plus fréquentes",
"headline": "Benzofuranes : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Benzofuranes : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-05",
"dateModified": "2025-04-01",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Benzofuranes"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Composés hétérobicycliques",
"url": "https://questionsmedicales.fr/mesh/D006574",
"about": {
"@type": "MedicalCondition",
"name": "Composés hétérobicycliques",
"code": {
"@type": "MedicalCode",
"code": "D006574",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Amiodarone",
"alternateName": "Amiodarone",
"url": "https://questionsmedicales.fr/mesh/D000638",
"about": {
"@type": "MedicalCondition",
"name": "Amiodarone",
"code": {
"@type": "MedicalCode",
"code": "D000638",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.127.075"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Dronédarone",
"alternateName": "Dronedarone",
"url": "https://questionsmedicales.fr/mesh/D000077764",
"about": {
"@type": "MedicalCondition",
"name": "Dronédarone",
"code": {
"@type": "MedicalCode",
"code": "D000077764",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.127.075.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Benzbromarone",
"alternateName": "Benzbromarone",
"url": "https://questionsmedicales.fr/mesh/D001553",
"about": {
"@type": "MedicalCondition",
"name": "Benzbromarone",
"code": {
"@type": "MedicalCode",
"code": "D001553",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.127.110"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Cantharidine",
"alternateName": "Cantharidin",
"url": "https://questionsmedicales.fr/mesh/D002193",
"about": {
"@type": "MedicalCondition",
"name": "Cantharidine",
"code": {
"@type": "MedicalCode",
"code": "D002193",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.127.125"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Citalopram",
"alternateName": "Citalopram",
"url": "https://questionsmedicales.fr/mesh/D015283",
"about": {
"@type": "MedicalCondition",
"name": "Citalopram",
"code": {
"@type": "MedicalCode",
"code": "D015283",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.127.187"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Escitalopram",
"alternateName": "Escitalopram",
"url": "https://questionsmedicales.fr/mesh/D000089983",
"about": {
"@type": "MedicalCondition",
"name": "Escitalopram",
"code": {
"@type": "MedicalCode",
"code": "D000089983",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.127.203"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Fura-2",
"alternateName": "Fura-2",
"url": "https://questionsmedicales.fr/mesh/D016257",
"about": {
"@type": "MedicalCondition",
"name": "Fura-2",
"code": {
"@type": "MedicalCode",
"code": "D016257",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.127.250"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Griséofulvine",
"alternateName": "Griseofulvin",
"url": "https://questionsmedicales.fr/mesh/D006118",
"about": {
"@type": "MedicalCondition",
"name": "Griséofulvine",
"code": {
"@type": "MedicalCode",
"code": "D006118",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.127.275"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Benzofuranes",
"alternateName": "Benzofurans",
"code": {
"@type": "MedicalCode",
"code": "D001572",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Zhi Xu",
"url": "https://questionsmedicales.fr/author/Zhi%20Xu",
"affiliation": {
"@type": "Organization",
"name": "School of Pharmacy, Guizhou University of Traditional Chinese Medicine, Guiyang 550025, Guizhou, P.R. China."
}
},
{
"@type": "Person",
"name": "Wei Zhou",
"url": "https://questionsmedicales.fr/author/Wei%20Zhou",
"affiliation": {
"@type": "Organization",
"name": "School of Pharmacy, Guizhou Medical University, Guiyang 550025, Guizhou, P.R. China."
}
},
{
"@type": "Person",
"name": "Ashraf A Abbas",
"url": "https://questionsmedicales.fr/author/Ashraf%20A%20Abbas",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, Faculty of Science, Cairo University Giza 12613 Egypt kmdawood@sci.cu.edu.eg +20-2-35727556 +20-2-35676602."
}
},
{
"@type": "Person",
"name": "Kamal M Dawood",
"url": "https://questionsmedicales.fr/author/Kamal%20M%20Dawood",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, Faculty of Science, Cairo University Giza 12613 Egypt kmdawood@sci.cu.edu.eg +20-2-35727556 +20-2-35676602."
}
},
{
"@type": "Person",
"name": "Giovanni Luca Beretta",
"url": "https://questionsmedicales.fr/author/Giovanni%20Luca%20Beretta",
"affiliation": {
"@type": "Organization",
"name": "Molecular Pharmacology Unit, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale Tumori, Via Amadeo 42, 20133 Milan, Italy."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Classification of Local Recurrence After Nipple-Sparing Mastectomy Based on Location: The Features of Nipple-Areolar Recurrence Differ from Those of Other Local Recurrences.",
"datePublished": "2022-11-13",
"url": "https://questionsmedicales.fr/article/36371582",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1245/s10434-022-12760-1"
}
},
{
"@type": "ScholarlyArticle",
"name": "Feasibility of local therapy for recurrent pancreatic cancer.",
"datePublished": "2022-05-24",
"url": "https://questionsmedicales.fr/article/35641368",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.pan.2022.05.004"
}
},
{
"@type": "ScholarlyArticle",
"name": "Ultrasound Assessment of Skin Tumors Local Recurrence.",
"datePublished": "2023-05-17",
"url": "https://questionsmedicales.fr/article/37195073",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/jum.16255"
}
},
{
"@type": "ScholarlyArticle",
"name": "Pathological determinants of outcome following resection of locally advanced or locally recurrent rectal cancer.",
"datePublished": "2023-06-26",
"url": "https://questionsmedicales.fr/article/37442715",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ejso.2023.06.023"
}
},
{
"@type": "ScholarlyArticle",
"name": "Intraparenchymal metastases as a cause for local recurrence of pancreatic cancer.",
"datePublished": "2022-11-21",
"url": "https://questionsmedicales.fr/article/36371607",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/his.14839"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Composés hétérocycliques",
"item": "https://questionsmedicales.fr/mesh/D006571"
},
{
"@type": "ListItem",
"position": 3,
"name": "Composés hétérocycliques à cycles fusionnés",
"item": "https://questionsmedicales.fr/mesh/D000072471"
},
{
"@type": "ListItem",
"position": 4,
"name": "Composés hétérobicycliques",
"item": "https://questionsmedicales.fr/mesh/D006574"
},
{
"@type": "ListItem",
"position": 5,
"name": "Benzofuranes",
"item": "https://questionsmedicales.fr/mesh/D001572"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Benzofuranes - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Benzofuranes",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-15",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Benzofuranes",
"description": "Comment diagnostiquer une intoxication aux benzofuranes ?\nQuels tests sont utilisés pour détecter les benzofuranes ?\nQuels symptômes indiquent une exposition aux benzofuranes ?\nLes benzofuranes sont-ils visibles sur des tests standards ?\nQuel rôle joue l'historique médical dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D001572?mesh_terms=Neoplasm+Recurrence,+Local#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Benzofuranes",
"description": "Quels sont les symptômes courants des benzofuranes ?\nLes benzofuranes provoquent-ils des effets psychologiques ?\nY a-t-il des symptômes cutanés associés aux benzofuranes ?\nLes benzofuranes affectent-ils le système respiratoire ?\nLes symptômes varient-ils selon la dose de benzofuranes ?",
"url": "https://questionsmedicales.fr/mesh/D001572?mesh_terms=Neoplasm+Recurrence,+Local#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Benzofuranes",
"description": "Comment prévenir l'exposition aux benzofuranes ?\nLes travailleurs doivent-ils être formés sur les benzofuranes ?\nQuelles mesures de sécurité sont recommandées en laboratoire ?\nLes benzofuranes sont-ils réglementés ?\nComment gérer les déchets contenant des benzofuranes ?",
"url": "https://questionsmedicales.fr/mesh/D001572?mesh_terms=Neoplasm+Recurrence,+Local#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Benzofuranes",
"description": "Quel traitement est recommandé pour l'intoxication aux benzofuranes ?\nDes antidotes existent-ils pour les benzofuranes ?\nComment traiter les symptômes neurologiques causés par les benzofuranes ?\nLes soins d'urgence sont-ils nécessaires pour l'exposition aux benzofuranes ?\nLa décontamination est-elle nécessaire après exposition ?",
"url": "https://questionsmedicales.fr/mesh/D001572?mesh_terms=Neoplasm+Recurrence,+Local#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Benzofuranes",
"description": "Quelles complications peuvent survenir après exposition aux benzofuranes ?\nLes benzofuranes peuvent-ils causer des maladies chroniques ?\nY a-t-il des effets à long terme des benzofuranes ?\nLes benzofuranes peuvent-ils affecter la reproduction ?\nComment surveiller les complications liées aux benzofuranes ?",
"url": "https://questionsmedicales.fr/mesh/D001572?mesh_terms=Neoplasm+Recurrence,+Local#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Benzofuranes",
"description": "Qui est à risque d'exposition aux benzofuranes ?\nLes benzofuranes sont-ils présents dans des produits courants ?\nL'âge influence-t-il la sensibilité aux benzofuranes ?\nLes antécédents médicaux augmentent-ils le risque ?\nLes benzofuranes affectent-ils différemment les sexes ?",
"url": "https://questionsmedicales.fr/mesh/D001572?mesh_terms=Neoplasm+Recurrence,+Local#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une intoxication aux benzofuranes ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'historique d'exposition et les tests toxicologiques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour détecter les benzofuranes ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des analyses de sang et d'urine peuvent être effectuées pour détecter ces composés."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une exposition aux benzofuranes ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des troubles neurologiques, des nausées et des palpitations."
}
},
{
"@type": "Question",
"name": "Les benzofuranes sont-ils visibles sur des tests standards ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, des tests spécifiques sont nécessaires pour détecter les benzofuranes."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'historique médical dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'historique médical aide à établir un lien entre les symptômes et l'exposition aux benzofuranes."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants des benzofuranes ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des vertiges, des maux de tête et des troubles de la vision."
}
},
{
"@type": "Question",
"name": "Les benzofuranes provoquent-ils des effets psychologiques ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent causer de l'anxiété, des hallucinations et des troubles de l'humeur."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes cutanés associés aux benzofuranes ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des éruptions cutanées et des démangeaisons peuvent survenir après exposition."
}
},
{
"@type": "Question",
"name": "Les benzofuranes affectent-ils le système respiratoire ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent provoquer des difficultés respiratoires et une irritation des voies respiratoires."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon la dose de benzofuranes ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la gravité des symptômes dépend de la dose et de la durée d'exposition."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'exposition aux benzofuranes ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des équipements de protection et suivre les protocoles de sécurité en laboratoire."
}
},
{
"@type": "Question",
"name": "Les travailleurs doivent-ils être formés sur les benzofuranes ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une formation sur les risques et les mesures de sécurité est essentielle."
}
},
{
"@type": "Question",
"name": "Quelles mesures de sécurité sont recommandées en laboratoire ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des hottes, des gants et des lunettes de protection lors de la manipulation."
}
},
{
"@type": "Question",
"name": "Les benzofuranes sont-ils réglementés ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, leur utilisation est souvent réglementée en raison de leur toxicité potentielle."
}
},
{
"@type": "Question",
"name": "Comment gérer les déchets contenant des benzofuranes ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les déchets doivent être éliminés selon les protocoles de gestion des déchets dangereux."
}
},
{
"@type": "Question",
"name": "Quel traitement est recommandé pour l'intoxication aux benzofuranes ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement comprend l'élimination de l'exposition et des soins symptomatiques."
}
},
{
"@type": "Question",
"name": "Des antidotes existent-ils pour les benzofuranes ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas d'antidote spécifique pour les benzofuranes."
}
},
{
"@type": "Question",
"name": "Comment traiter les symptômes neurologiques causés par les benzofuranes ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments peuvent être prescrits pour gérer les symptômes neurologiques."
}
},
{
"@type": "Question",
"name": "Les soins d'urgence sont-ils nécessaires pour l'exposition aux benzofuranes ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des soins d'urgence peuvent être nécessaires en cas d'exposition sévère."
}
},
{
"@type": "Question",
"name": "La décontamination est-elle nécessaire après exposition ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la décontamination est essentielle pour réduire l'absorption des benzofuranes."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir après exposition aux benzofuranes ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications neurologiques, respiratoires et dermatologiques peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les benzofuranes peuvent-ils causer des maladies chroniques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une exposition prolongée peut augmenter le risque de maladies chroniques."
}
},
{
"@type": "Question",
"name": "Y a-t-il des effets à long terme des benzofuranes ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des effets à long terme incluent des troubles cognitifs et des problèmes respiratoires."
}
},
{
"@type": "Question",
"name": "Les benzofuranes peuvent-ils affecter la reproduction ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines études suggèrent qu'ils peuvent avoir des effets néfastes sur la reproduction."
}
},
{
"@type": "Question",
"name": "Comment surveiller les complications liées aux benzofuranes ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi médical régulier est recommandé pour détecter les complications précoces."
}
},
{
"@type": "Question",
"name": "Qui est à risque d'exposition aux benzofuranes ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les travailleurs en laboratoire et ceux manipulant des produits chimiques sont à risque."
}
},
{
"@type": "Question",
"name": "Les benzofuranes sont-ils présents dans des produits courants ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent être présents dans certains produits chimiques et médicaments."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il la sensibilité aux benzofuranes ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les jeunes enfants et les personnes âgées peuvent être plus sensibles."
}
},
{
"@type": "Question",
"name": "Les antécédents médicaux augmentent-ils le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents de maladies respiratoires ou neurologiques peuvent augmenter le risque."
}
},
{
"@type": "Question",
"name": "Les benzofuranes affectent-ils différemment les sexes ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études suggèrent que les effets peuvent varier entre les sexes, mais les données sont limitées."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 01/04/2025
Contenu vérifié selon les dernières recommandations médicales
2 publications dans cette catégorie
Affiliations :
School of Pharmacy, Guizhou University of Traditional Chinese Medicine, Guiyang 550025, Guizhou, P.R. China.
Publications dans "Benzofuranes" :
2 publications dans cette catégorie
Affiliations :
School of Pharmacy, Guizhou Medical University, Guiyang 550025, Guizhou, P.R. China.
Publications dans "Benzofuranes" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry, Faculty of Science, Cairo University Giza 12613 Egypt kmdawood@sci.cu.edu.eg +20-2-35727556 +20-2-35676602.
Publications dans "Benzofuranes" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry, Faculty of Science, Cairo University Giza 12613 Egypt kmdawood@sci.cu.edu.eg +20-2-35727556 +20-2-35676602.
Publications dans "Benzofuranes" :
2 publications dans cette catégorie
Affiliations :
Molecular Pharmacology Unit, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale Tumori, Via Amadeo 42, 20133 Milan, Italy.
Publications dans "Benzofuranes" :
2 publications dans cette catégorie
Affiliations :
Department of Food, Environmental and Nutritional Sciences (DeFENS), University of Milan, Via Celoria 2, 20133 Milan, Italy.
Publications dans "Benzofuranes" :
2 publications dans cette catégorie
Affiliations :
Department of Food, Environmental and Nutritional Sciences (DeFENS), University of Milan, Via Celoria 2, 20133 Milan, Italy.
Publications dans "Benzofuranes" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry, Indian Institute of Technology Guwahati Assam 781039 India span@iitg.ac.in https://www.iitg.ac.in/span/.
Publications dans "Benzofuranes" :
2 publications dans cette catégorie
Affiliations :
Institute of Chemical Technology Mumbai IOC Odisha Campus Bhubaneswar Bhubaneswar 751013 India.
Publications dans "Benzofuranes" :
2 publications dans cette catégorie
Affiliations :
Institute of Chemical Technology Mumbai IOC Odisha Campus Bhubaneswar Bhubaneswar 751013 India.
Publications dans "Benzofuranes" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry, Indian Institute of Technology Guwahati Assam 781039 India span@iitg.ac.in https://www.iitg.ac.in/span/.
Publications dans "Benzofuranes" :
2 publications dans cette catégorie
Affiliations :
School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, China.
Guangdong Engineering Research Center for Lead Compounds & Drug Discovery, Guangzhou 510006, China.
Publications dans "Benzofuranes" :
2 publications dans cette catégorie
Affiliations :
School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, China.
Guangdong Engineering Research Center for Lead Compounds & Drug Discovery, Guangzhou 510006, China.
Publications dans "Benzofuranes" :
2 publications dans cette catégorie
Affiliations :
School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, China.
Guangdong Engineering Research Center for Lead Compounds & Drug Discovery, Guangzhou 510006, China.
Publications dans "Benzofuranes" :
2 publications dans cette catégorie
Affiliations :
School of Chinese Materia Medica, Yunnan University of Chinese Medicine, Kunming 650500, P.R. China.
Publications dans "Benzofuranes" :
2 publications dans cette catégorie
Affiliations :
School of Chinese Materia Medica, Yunnan University of Chinese Medicine, Kunming 650500, P.R. China.
Publications dans "Benzofuranes" :
2 publications dans cette catégorie
Affiliations :
Central laboratory, The NO.1 Affiliated Hospital of Yunnan University of Chinese Medicine, Kunming 650021, P.R. China.
Publications dans "Benzofuranes" :
2 publications dans cette catégorie
Affiliations :
School of Chinese Materia Medica, Yunnan University of Chinese Medicine, Kunming 650500, P.R. China.
Publications dans "Benzofuranes" :
2 publications dans cette catégorie
Affiliations :
Institute of Organic Chemistry of Polish Academy of Sciences, Kasprzaka 44/52, 01-224, Warsaw, Poland.
Publications dans "Benzofuranes" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry, Government College University Faisalabad, 38000 Faisalabad, Pakistan.
Publications dans "Benzofuranes" :
Little information is available about the clinical and pathologic characteristics of local recurrence (LR) after nipple-sparing mastectomy according to the locations of LR....
This study classified 99 patients into the following two groups according to the location of LR after nipple-sparing mastectomy: nipple-areolar recurrence (NAR) group and other locations of LR (oLR) g...
For about half of the patients (44.4 %) with NAR, the primary cancer was estrogen receptor (ER)-negative and human epidermal growth factor receptor 2 (HER2)-positive. Conversely, in most of the patien...
This multi-institutional retrospective study demonstrated that the features of NAR, such as the characteristics of the primary and recurrent tumors and the prognostic factors after LR resection, were ...
Despite advances in perioperative management, recurrence after curative pancreatectomy is a critical issue in the treatment of pancreatic ductal adenocarcinoma (PDAC). The significance of local therap...
We reviewed the medical records of patients with PDAC who underwent curative resection at our institution between January 2009 and December 2019. We examined the patterns of relapse and assessed the c...
A total of 246 patients with PDAC who underwent R0 or R1 resection were included in this study. The 3-year overall survival (OS) rate was 39.8%, and the 1-year recurrence-free survival rate was 51.2% ...
Our results suggest that a multimodal approach may improve the clinical outcomes of patients with recurrent PDAC....
Skin cancer may recur at or around the surgical site despite wide excisions. Prompt clinical and sonographic detection of local recurrence is important since subjects with relapsing melanomas or nonme...
Pathological factors that influence and predict survival following pelvic exenteration (PE) for locally advanced (LARC) or locally recurrent rectal cancer (LRRC), especially LRRC, remain poorly unders...
A retrospective cohort study was performed for all patients undergoing a curative PE for LARC or LRRC between 2008 and 2021 at a tertiary referral UK specialist colorectal hospital. Cox regression ana...
388 patients were included in the analysis with 256 resections for LARC and 132 for LRRC. 62.4% of patients were male with a median age of 59 years (IQR 49-67). 247 (64%) partial pelvic exenterations ...
A positive resection margin and poorly differentiated tumours are significant negative prognostic markers for survival and recurrence in LARC. The results of this study support the need to look for al...
Using CODA, a technique for three-dimensional reconstruction of large tissues, Kiemen et al. report observation of a microscopic focus of pancreatic cancer found in the vasculature of grossly normal h...
The initial approach to the treatment of desmoid tumors has changed from surgical resection to watchful waiting. However, surgery is still sometimes considered for some patients, and it is likely that...
We sought to explore whether a combined molecular and clinical prognostic model for relapse in patients with desmoid tumors treated with surgery would allow us to identify patients who might do well w...
This was a retrospective, single-center study of 107 patients with desmoid tumors who were surgically treated between January 1980 and December 2015, with a median follow-up of 106 months (range 7 to ...
The multivariable analysis showed that S45F mutations (hazard ratio 5.25 [95% confidence interval 2.27 to 12.15]; p < 0.001) and tumor in the extremities (HR 3.15 [95% CI 1.35 to 7.33]; p = 0.008) wer...
CTNNB1 S45F mutations combined with other clinical variables are a potential prognostic biomarker associated with the risk of relapse in patients with desmoid tumors. The developed nomogram is simple ...
Level III, therapeutic study....
A first local recurrence is common after resection or radiotherapy for brain metastasis (BM). However, patients with BMs can develop multiple local recurrences over time. Published data on second loca...
Patients were identified from a database at Brigham and Women's Hospital in Boston. Hazard ratios and 95% confidence intervals for predictors of a second local recurrence were computed using a Cox pro...
Of 170 identified surgically treated first locally recurrent lesions, 74 (43.5%) progressed to second locally recurrent lesions at a median of 7 months after craniotomy. Subtotal resection of the firs...
A second local recurrence occurred after 43.5% of craniotomies for first recurrent lesions. Subtotal resection and infratentorial location were the strongest risk factors for worse second local recurr...
The current study was undertaken to provide more detailed prognostic models for early prediction of local recurrences and local recurrence free survival (RFS) using different radiologic and pathologic...
One hundred patients with locally advanced rectal carcinomas decided to receive neoadjuvant CRT were retrospectively recruited, Hazard ratios (HR) were determined in the two cox regression models and ...
HR of 1st group of models: T+N, T+N+G, T+N+G+S, T+N+G+S+PNI, and T+N+G+S+PNI+R were summated and categorized into scores, these scores were significantly correlated with the risk of recurrence (Somer'...
We propose that the addition of biologic factors to staging of rectal cancer provide precise stratification and association with local recurrences in patients received preoperative CRT....
This study aims to identify prognostic factors and define the best extent of surgery for optimizing treatment of local recurrence (LR) following colorectal cancer (CRC)....
An institutional database of consecutive patients who underwent radical resection (R0/R1) of LR following CRC was analyzed prospectively from 2010 to 2021 at one tertiary cancer center....
In this study, 75 patients were included with LR following CRC and analyzed. Patients were categorized as compartmental resections (CompRe) (n = 47) if all adjacent organs were systematically removed,...
Complete compartmental surgery is safe and improves local control. Optimal LR resection needs to remove all contiguous organs, with or without tumor involvement....
RET-fused mesenchymal neoplasms mostly affect the soft tissue of paediatric patients. Given their responsiveness to selective RET inhibitors, it remains critical to identify those extraordinary cases ...
Clinicopathological features were assessed and partner agnostic targeted next-generation sequencing on clinically validated platforms were performed. The patients were 18, 53, and 55 years old and inc...
Our study expands the clinicopathological and genetic spectrum of mesenchymal neoplasms associated with RET fusions....